Importer of Controlled Substances; Notice of Registration, 17471 [05-6797]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 65 / Wednesday, April 6, 2005 / Notices
17471
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Schedule
the public interest at this time. DEA has
investigated Aldrich Chemical
Company, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6794 Filed 4–5–05; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By notice dated December 21, 2004
and published in the Federal Register
on January 4, 2005 (70 FR 389),
Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Phenylacetone (8501), a basic class of
controlled substances listed in Schedule
II.
The company plans to import the
phenylacetone to manufacture
amphetamine for distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cambrex Charles City, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Cambrex Charles City, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
18:17 Apr 05, 2005
Jkt 205001
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application; Correction
BILLING CODE 4410–09–P
VerDate jul<14>2003
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6797 Filed 4–5–05; 8:45 am]
By Notice dated December 21, 2004,
and published in the Federal Register
on January 4, 2005, (70 FR 390), the
listing of controlled substances N–
Ethylamphetamine (1475), 2,5–
Dimethoxyamphetamine (7396), 4–
Methoxyamphetamine (7411), and
Difenoxin (9168), were inadvertently
added for Chattem Chemicals, Inc., 3801
St. Elmo Avenue, Building 18,
Chattanooga, Tennessee 37409. The
Notice of Application should be
corrected by deleting N–
Ethylamphetamine (1475), 2,5–
Dimethoxyamphetamine (7396), 4–
Methoxyamphetamine (7411), and
Difenoxin (9168).
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6788 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
Drug
2,5–Dimethoxyamphetamine
(7396).
4–Methoxyamphetamine (7411) ...
Difenoxin (9168) ...........................
Methamphetamine (1105) ............
Raw Opium (9600) .......................
Concentrate of Poppy Straw
(9670).
I
I
I
II
II
II
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. Sections 823(a) and
952(a) and determined that the
registration of Cambrex Charles City,
Inc. to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Cambrex Charles City,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
Sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substance listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6795 Filed 4–5–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Importer of Controlled Substances;
Notice of Registration
Drug Enforcement Administration
By Notice dated December 21, 2004
and published in the Federal Register
on January 4, 2005, (70 FR 390),
Chattem Chemicals Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in Schedule
I and II:
Drug
Schedule
N–Ethylamphetamine (1475) ........
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
I
Manufacturer of Controlled
Substances; Notice of Application;
Correction
By notice dated July 21, 2004, and
published in the Federal Register on
August 10, 2004 (69 FR 48522), Dade
Behring Inc., Route 896 Corporate
Boulevard, Building 100, Attention: RA/
QA, Post Office Box 6101, Newark,
Delaware 19717 made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer, and to modify its
address. The address modification was
inadvertently omitted. The state of
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Page 17471]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6797]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By notice dated December 21, 2004 and published in the Federal
Register on January 4, 2005 (70 FR 389), Cambrex Charles City, Inc.,
1205 11th Street, Charles City, Iowa 50616, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as an
importer of Phenylacetone (8501), a basic class of controlled
substances listed in Schedule II.
The company plans to import the phenylacetone to manufacture
amphetamine for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cambrex Charles City, Inc. to import the basic classes
of controlled substances is consistent with the public interest and
with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Cambrex Charles City, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic class of controlled substance
listed.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6797 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-M
